On Wednesday, Sequenom, Inc. (NASDAQ:SQNM)’s shares showed no change to $3.13.
Sequenom, Inc. (SQNM) a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced today the upcoming launch of the MaterniT™ GENOME laboratory-developed test. This test is the first noninvasive prenatal test (NIPT) to provide karyotype-level insight into fetal chromosomal status prior to considering an invasive procedure. The MaterniT GENOME test adds genome-wide identification of chromosomal gains or losses greater than 7 megabases (Mb) in size to Sequenom Laboratories’ growing NIPT testing portfolio.
The MaterniT GENOME test builds upon the industry leading microdeletion performance demonstrated by Sequenom Laboratories with the MaterniT21 PLUS laboratory-developed test, which was recently highlighted in an article by Hume JH, et al, published in the peer-reviewed journal Prenatal Diagnosis. Data supporting the validation of the MaterniT GENOME test will be presented at the 19th International Conference on Prenatal Diagnosis and Treatment (sponsored by the International Society of Prenatal Diagnosis and Therapy - ISPD) in Washington D.C., taking place July 12-15, 2015. The MaterniT GENOME test will be accessible to physicians later this quarter.
Sequenom, Inc., a life sciences company, develops and commercializes molecular diagnostics testing services for the women’s health and oncology markets in the United States and internationally. The company provides molecular based laboratory developed tests (LDTs) comprising MaterniT21 PLUS LDT, a noninvasive prenatal test (NIPT) to detect fetal chromosomal abnormalities; HerediT CF LDT, a carrier screen test to identify individuals with cystic fibrosis or genetic mutations; SensiGene fetal Rhesus D (RhD) LDT, a NIPT to determine the presence or absence of RhD factor by direct detection of the fetal RhD genotype in RhD negative mothers from a maternal blood sample; and VisibiliT LDT, a NIPT to detect fetal chromosomal abnormalities by determining the relative amount of chromosomal material present in circulating cell-free DNA in a maternal blood sample.
Habit Restaurants Inc (NASDAQ:HABT)’s shares dropped -7.90% to $28.93.
The Habit Restaurants, Inc. (HABT) declared that it plans to release its second quarter 2015 financial results for the period ended June 30, 2015 on August 5, 2015 shortly after the market closes.
In connection with the earnings release, The Habit will host a conference call to talk about its second quarter 2015 financial results on Wednesday, August 5, 2015 at 5:00 PM Eastern Time. Hosting the call will be Russ Bendel, chief executive officer and president, and Ira Fils, chief financial officer.
The Habit Restaurants, Inc. operates fast casual restaurants under The Habit Burger Grill name in California, Arizona, Utah, and New Jersey. The company offers charbroiled hamburgers, specialty sandwiches, fresh salads, and shakes and malts. As of April 30, 2015, it operated 114 restaurants in 10 markets. The Habit Restaurants, Inc. was founded in 1969 and is headquartered in Irvine, California.
At the end of Wednesday’s trade, JDS Uniphase Corp (NASDAQ:JDSU)‘s shares dipped -1.15% to $11.15.
JDSU (JDSU) declared that it continues to expect to spin off its communications and commercial optical products business into a separate, publicly-traded company, Lumentum Holdings Inc. (“Lumentum”), in the third calendar quarter of 2015. Existing filings with the Securities and Exchange Commission indicate a distribution date of July 26, 2015. JDSU is ongoing the customary regulatory process, and is targeting a revised separation date in August. JDSU will confirm definitive separation, record and distribution dates once the regulatory process is accomplished.
JDS Uniphase Corporation provides network and service enablement solutions and optical products worldwide. The company’s Network and Service Enablement segment offers network and service enablement solutions that enable the design, development, deployment, and maintenance of communication equipment and networks. This segment’s product portfolio comprises of test tools, platforms, microprobes, software, and services for wireless and fixed networks.
Harris Corporation (NYSE:HRS), ended its Wednesday’s trading session with 1.61% gain, and closed at $82.09.
Harris Corporation (HRS) declared that it will maintain corporate headquarters and base two of its newly formed segments in Florida. The declarement follows the company’s acquisition of Exelis Inc. and its decision earlier this month to reorganize into four market-focused segments.
Harris will maintain corporate headquarters in Melbourne, Florida. Harris has been headquartered in Florida since 1978 and has had a noteworthy presence in the state for more than 65 years. The company recently has about 6,000 Florida employees, counting 3,200 engineers and scientists, and is the only top 10 defense contractor headquartered in the state. Florida is the primary hub for the company’s $1 billion research and development activity — principally located at its new Harris Technology Center in Palm Bay, Florida.
Harris Corporation, together with its auxiliaries, operates as an international communications and information technology company worldwide. The company operates through RF Communications, Integrated Network Solutions, and Government Communications Systems segments. The RF Communications segment supplies secure tactical radio communications and high-grade encryption solutions for military, government, and commercial customers, in addition to secure communications systems and equipment for public safety, utility, and transportation customers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.